Declaration of interest
AD Santin reports grants from Puma, grants from Immunomedics, grants from Gilead, grants from Synthon, grants and personal fees from Merck, grants from Boehringer-Ingelheim, grants from Genentech, grants and personal fees from Tesaro and grants and personal fees from Eisai and R-Pharm U.S.A. The other authors declare no conflict of interest. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.